Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PLX PHARMA INC.

(PLXP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PLx Shares Rise as Walgreens Set to Carry Vazalore in Stores

07/20/2021 | 10:42am EDT

By Robb M. Stewart

PLx Pharma Inc.'s shares jumped Tuesday ahead of the launch of its liquid-filled aspirin capsules in Walgreens stores in the U.S. next month.

In morning trading, the shares were 17% higher at $19.95, adding to a strong rally since the end of last year.

PLx late Monday said its U.S. Food and Drug Administration-approved Vazalore will be available in more than 8,000 Walgreens stores nationwide later in August. The retail pharmacy has already inserted placeholders to reserve space on shelves for the three variants of Vazalore, a 81 mg 12 count, 81 mg 30 count and a 325 mg 30 count, it said.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

07-20-21 1041ET

Stocks mentioned in the article
ChangeLast1st jan.
PLX PHARMA INC. 1.38% 17.315 Delayed Quote.209.42%
WALGREENS BOOTS ALLIANCE, INC. -0.92% 49.66 Delayed Quote.25.68%
All news about PLX PHARMA INC.
09/09PLX PHARMA : to Present at Upcoming Virtual Healthcare Industry Conferences
AQ
08/26PLX PHARMA : Announces Nationwide Rollout of Aspirin Capsules
MT
08/26PLX PHARMA : VAZALORE™ Now on Shelves; National Media Campaign Launches To..
AQ
08/06PLX PHARMA INC. : Entry into a Material Definitive Agreement, Financial Statemen..
AQ
08/06PLX PHARMA : Q2 Loss Widens
MT
08/06PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
08/06Plx Pharma Inc. Reports Earnings Results for the Second Quarter Ended June 30..
CI
08/06PLX PHARMA INC. : Results of Operations and Financial Condition, Financial State..
AQ
08/06PLX PHARMA : Reports Second Quarter 2021 Results and Provides Business Update
AQ
08/03PLX PHARMA : to Launch Vazalore in 8,000 CVS Stores in August
MT
More news
Analyst Recommendations on PLX PHARMA INC.
More recommendations
Financials (USD)
Sales 2021 9,97 M - -
Net income 2021 -45,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -8,26x
Yield 2021 -
Capitalization 459 M 459 M -
Capi. / Sales 2021 46,1x
Capi. / Sales 2022 14,9x
Nbr of Employees 10
Free-Float 89,5%
Chart PLX PHARMA INC.
Duration : Period :
PLx Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PLX PHARMA INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 17,08 $
Average target price 21,50 $
Spread / Average Target 25,9%
EPS Revisions
Managers and Directors
Natasha Giordano President, Chief Executive Officer & Director
Rita M. O'Connor CFO, Head-Manufacturing & Supply Chain
Michael J. Valentino Executive Chairman
Gary S. Balkema Independent Director
Kirk K. Calhoun Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PLX PHARMA INC.209.42%459
GILEAD SCIENCES, INC.23.17%89 973
BIONTECH SE335.78%85 800
REGENERON PHARMACEUTICALS34.96%67 787
WUXI APPTEC CO., LTD.28.41%64 886
VERTEX PHARMACEUTICALS-20.09%48 996